Article
Low vulnerability of the posterior eye segment to SARS-CoV2 infection
Search Medline for
Authors
Published: | January 10, 2022 |
---|
Outline
Text
Purpose: Retinal manifestations have been described in COVID-19 patients, but it is unknown whether SARS-CoV-2, the causal agent in COVID-19, can directly infect posterior ocular tissues. Here, we investigate SARS-CoV-2 host factor gene expression levels and their distribution across retinal and choroidal cell types.
Methods: Query of single-cell RNA sequencing data from human retina and choroid.
Results: We find no relevant expression of two key genes involved in SARS-CoV-2 entry, ACE2 and TMPRSS2, in retinal cell types. By contrast, scarce expression levels could be detected in choroidal vascular cells.
Conclusion: Given the current understanding of viral host-cell entry, these findings suggest a low vulnerability of the posterior eye segment to SARS-CoV-2 with a potential weak spot in the vasculature, which could play a putative causative role in ocular lesions in COVID-19 patients. This may qualify the vasculature of the human posterior eye segment as an in-vivo biomarker for life-threatening vascular occlusions in COVID-19 patients